Elisabeth Schaffner-Reckinger

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Top Venues

Journal of medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

Cell communication and signaling : CCS

This page only lists publications with an associated author ORCID identifier.

Publications

Pelin Kaya, Elisabeth Schaffner-Reckinger, Ganesh Babu Manoharan, Vladimir Vukic, Alexandros Kiriazis, Mirko Ledda, Maria Burgos Renedo, Karolina Pavic, Anthoula Gaigneaux, Enrico Glaab, Daniel Kwaku Abankwa
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell Growth. Journal of medicinal chemistry 67 (11) (2024)
Pelin Kaya, Elisabeth Schaffner-Reckinger, Ganesh Babu Manoharan, Vladimir Vukic, Alexandros Kiriazis, Mirko Ledda, Maria Burgos Renedo, Karolina Pavic, Anthoula Gaigneaux, Enrico Glaab, Daniel Kwaku Abankwa
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell Growth. Journal of medicinal chemistry 67 (11) (2024)
Pelin Kaya, Elisabeth Schaffner-Reckinger, Ganesh Babu Manoharan, Vladimir Vukic, Alexandros Kiriazis, Mirko Ledda, Maria Burgos Renedo, Karolina Pavic, Anthoula Gaigneaux, Enrico Glaab, Daniel Kwaku Abankwa
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell Growth. Journal of medicinal chemistry 67 (11) (2024)
Pelin Kaya, Elisabeth Schaffner-Reckinger, Ganesh Babu Manoharan, Vladimir Vukic, Alexandros Kiriazis, Mirko Ledda, Maria Burgos Renedo, Karolina Pavic, Anthoula Gaigneaux, Enrico Glaab, Daniel Kwaku Abankwa
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell Growth. Journal of medicinal chemistry (2024)
Claudia Cipriani, Maria Pires Pacheco, Ali Kishk, Maryem Wachich, Daniel Kwaku Abankwa, Elisabeth Schaffner-Reckinger, Thomas Sauter
Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Raquel A C Machado, Dunja Stojevski, Sébastien De Landtsheer, Philippe Lucarelli, Alexandre Baron, Thomas Sauter, Elisabeth Schaffner-Reckinger
L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasiveness. Cell communication and signaling : CCS 19 (1) (2021)